Amoeba Competitors and Similar CompaniesClear all
Amoeba's competitors and similar companies include XVIVO Perfusion and CellFE.
 Amoeba Amoeba SA is a France-based company that develops, manufactures and markets biological products. |  XVIVO Perfusion XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions. |  CellFE CellFE is a company that develops a microfluidic device designed to deliver gene-editing molecules into the human cells. | |
Founding Date | Founding Date 2010 | Founding Date 1998 | Founding Date 2018 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Chassieu, FR HQ Montréal, CA | Locations Mölndal, SE HQ Shanghai, CN Novegro Tregarezzo, IT Groningen, NL Lund, SE Mölndal, SE Aurora, US see more | Locations Alameda, US HQ |
Employees | Employees 1436% decrease | Employees 19320% increase | Employees 287% decrease |
Valuation ($) | Valuation ($) 35.2 m | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr812.2m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods kr208.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit €695k (FY, 2025) | Gross profit kr605.4m (FY, 2025) | Gross profit N/A |
Net income | Net income (€8.3m) (FY, 2025) | Net income kr25.2m (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
XVIVO Perfusion
HQ
Mölndal, SE
Employees
193↑ 20% increase
XVIVO Perfusion is a medical technology company that develops machines and perfusion solutions.
View companyCellFE
HQ
Alameda, US
Employees
28↓ 7% decrease
CellFE is a company that develops a microfluidic device designed to deliver gene-editing molecules into the human cells.
View company